Acoustic neuromas are benign tumors
that grow on the nerve for hearing
and balance. The nerve for hearing
and balance is more properly called
the vestibulocochlear nerve or the
eighth cranial nerve. This nerve
exits from the brainstem along with
the facial nerve (seventh cranial
nerve) and travels through the
cerebellopontine angle to enter the
internal auditory canal. The
vestibulocochlear nerve then divides
into a cochlear portion, which
enters the cochlea and carries
hearing, and a vestibular portion,
which enters the labyrinth and
carries balance information.
Acoustic neuromas should more
properly be called vestibular
schwannomas since they arise from
the Schwann cells (cells that cover
nerves in the central nervous
system) and occur most commonly on
the vestibular portion of the
vestibulocochlear (eighth cranial
nerve).
These
tumors are rare. They occur in 1
person per 100,000 people per year.
These tumors can occur either
sporadically or as part of an
inherited disorder. The sporadic
tumors happen on only one side. The
inherited disorder is associated
with bilateral acoustic neuromas or
a unilateral acoustic neuroma along
with other brain or nerve tumors.
This inherited disorder is called
neurofibromatosis type 2, or NF-2;
and is inherited in an autosomal
dominant trait. Both NF-2 and
sporadic cases of acoustic neuromas
are associated with an abnormality
on chromosome 22.
The
most common symptom of acoustic
neuroma is hearing loss. This
hearing loss is usually a
unilateral, slowly progressive
sensorineural hearing loss.
However, some patients experience a
sudden (<3 days) onset of hearing
loss; and yet other patients have
little or no hearing loss. On
audiometric
testing,
pure tone hearing, speech
discrimination and/or loss of
acoustic reflexes might signify the
presence of an acoustic neuroma.
Along
with unilateral hearing loss, a
ringing sound (also called tinnitus)
in one ear is a common symptom of an
acoustic neuroma. However, acoustic
neuromas do not produce a
characteristic tinnitus. This
tinnitus is usually a constant sound
in just one ear that has been
present for more than two months.
Although these tumors occur on the
vestibular portion of the eighth
nerve, vertigo is an uncommon
symptom of acoustic neuromas. More
often, patients complain of an
off-balance sensation, especially if
turning quickly. It is theorized
that since these tumors grow slowly
that the brain compensates for the
unilateral vestibular loss nearly
simultaneously. Vestibular testing
(ENG)
can sometimes show the vestibular
loss due to an acoustic neuroma.
Since
the facial nerve travels with the
vestibulocochlear nerve into the
internal auditory canal, facial
paralysis might occur as these
tumors grow larger and larger (>3
cm).
Other
symptoms of acoustic neuroma are
headache, blurred vision, numbness
of the face, hydrocephalus, or even
death (if allowed to grow
unchecked). These symptoms usually
do not occur until the tumors have
reached a large size (>4 cm).
Although these symptoms are found in
patients with acoustic neuromas,
none are specific enough to diagnose
a tumor. An audiogram is a
necessary test in the evaluation of
these symptoms and is an essential
step in diagnosing an acoustic
neuroma. If there is a significant
amount of hearing loss or other
symptoms to suggest an acoustic
neuroma, then an ABR (auditory
brainstem response)
might be used to evaluate further
the reason for the hearing loss.
ABR
is a sensitive test for picking up
tumors that are larger than 1 cm in
size. Smaller tumors might escape
detection with ABR alone. Abnormal
ABR findings demand further
evaluation by MRI.
Ultimately, an MRI (magnetic
resonance imaging) with Gadolinium
contrast is required to diagnose
these tumors.
This
type of imaging study gives an
exquisite view of the brain and the
cranial nerves. In patients with an
acoustic neuroma, the gadolinium
contrast is picked up by the tumor
cells and makes the tumor stand out
from the surrounding normal brain
and nerve tissues. MRI can pick up
tumors that are as small as 1 mm.
MRI scans permit a means of
measuring the tumor's size, which
can be used to monitor the tumor's
growth, if desired.
CT
(computerized tomography) scans with
contrast can be used to evaluate
patients who cannot otherwise have
MRI scanning. CT lacks the fine
detail found on MRI, but can
reliably demonstrate tumors larger
than 1-2 cm.
(Back
to Top)
In
general, treatment can be divided
into three options:
-
Surgery
-
Radiotherapy
-
Observation
The
goal of surgery is to remove
completely the tumor and preserve as
much normal function as possible.
All of these procedures are
performed under general anesthesia.
During every procedure, the function
of the facial nerve is monitored.
In patients with measurable hearing,
hearing can be monitored using
intraoperative ABR. All patients
will spend the first night after
surgery in the surgical ICU. The
patient is transferred to a regular
room as his or her condition
permits, usually on the day
following surgery. Patients should
plan on spending one week in the
hospital, but usually only 4 -5 days
of total hospitalization are
required.
The
choice of surgical approach is based
on several factors: (1) size of the
tumor, (2) status of hearing, and
(3) experience of the surgeon.
Other factors, such as facial or
other cranial nerve status and
patient preference, are also
considerations. The three surgical
approaches for removal of acoustic
neuromas each have their own
advantages and disadvantages:
-
Middle cranial fossa approach
-
Retrosigmoid/suboccipital
approach
-
Translabyrinthine approach
In
this approach, an incision is made
in the skin above and behind the
ear. Next, a small window of skull
bone above the ear is removed, and
the dura of the temporal lobe is
elevated exposing the bone of the
middle cranial fossa. Using a
microscope and drill, this bone is
removed and the internal auditory
canal is exposed. The dura of the
internal auditory canal is incised,
and the tumor is exposed. The tumor
is then separated from the facial
nerve and, possibly, the cochlear
nerve. The tumor is then removed.
The operative site is then closed by
using a small plug of muscle and a
bone graft in the middle fossa
defect. The window of bone, removed
at the start of the procedure, is
replaced and sometimes affixed with
microsurgical plates. The soft
tissues are then closed in layers.
A sterile pressure dressing is then
applied.
Since
this procedure leaves the inner ear
intact, it is an approach for
potential hearing preservation.
This
approach goes through the bone
behind the sigmoid sinus (the large
vein that drains blood from that
side of the brain) at the back of
the head (the occiput). Once the
skin and soft tissue over the skull
is opened, an opening in the occiput
is created. Using a microscope, the
dura is opened and the lateral lobe
of the cerebellum is moved toward
the midline. This movement exposes
the tumor within the
cerebellopontine angle; and this
portion of the tumor is separated
from the facial nerve and removed.
Oftentimes, the tumor extends into
the internal auditory canal. Using
a fine drill, the bone of the canal
is removed and the remaining portion
of tumor is removed. A plug of soft
tissue is used to close the internal
auditory canal. The cerebellum is
allowed to return to its normal
position and the dura covering it is
closed. The soft tissues and skin
are closed in layers, and a sterile
dressing is applied.
Since
this procedure leaves the inner ear
intact, it is an approach for
potential hearing preservation.
This
approach goes through the mastoid
and the labyrinth (the balance
organs) in order to expose the
internal auditory canal and the
tumor. The skin is incised about 4
cm behind the ear. The bone of the
mastoid and temporal bone is exposed
and opened using a high speed drill
and microscope. The facial nerve is
identified within the temporal bone
and preserved; the labyrinth is
removed. The bone of the internal
auditory canal and the posterior
fossa is removed. The dura covering
these structures is opened,
exposing the tumor. The tumor is
separated from the facial nerve; the
vestibular nerves are divided, and
the tumor is removed. Once the
tumor has been removed, closure
occurs by harvesting a portion of
fat from the abdomen and using this
tissue to plug the hole in the dura.
The soft tissues and skin are then
closed in layers, followed by a
sterile dressing.
Since
this procedure removes the inner
ear, it is not possible to save
hearing in the operated ear.
Risks and Complications of Surgery
All
surgical procedures have potential
problems and expected outcomes. The
most common potential problems and
outcomes will be described as
enumerated below:
-
Hearing loss. Many
patients with acoustic neuromas
already have hearing loss.
However, a small number of
patients have small tumors (<1.5
cm) and good hearing. Hearing
preservation can be attempted by
using either the retrosigmoid
approach or the middle fossa
approach. Success rates of
hearing preservation, even in
the best of circumstances,
however, are only about 30%.
Even more uncommon is hearing
improvement, although we have
operated on patients who
experienced this improvement.
Hearing loss from this surgery
is more often an expected
outcome from the surgery.
-
Dizziness. Due to the
slow growth of these tumors,
many patients have already
adapted to the loss vestibular
input from the tumor side.
Regardless of the approach
taken, the loss of vestibular
input from surgery will be
complete. Young patients (those
less than 65 years of age) will
usually recover their balance
quickly (within one month).
Persistent imbalance can occur
and usually vestibular
rehabilitation will help to
improve the patient's balance.
-
Tinnitus. This is a
common symptom of acoustic
neuroma. Removing the tumor
does not necessarily change,
improve, or diminish the
tinnitus. Even in patient with
hearing preservation might
continue to have tinnitus
following surgery. Most
patients seem to accommodate to
this tinnitus after the surgery.
-
Facial paralysis.
Avoiding facial paralysis has
been the major advancement in
acoustic neuroma surgery over
the last 10 - 15 years. The use
of facial nerve monitors has
helped surgeons to identify the
facial nerve, and thus preserve
its function. Large tumors (>3
cm in size) are harder to remove
and preserve facial function.
Some smaller tumors can be
difficult to separate from the
facial nerve as well, especially
if the tumor is hard and
fibrous. If the nerve can be
anatomically preserved,
frequently its function will
return to near normal function.
Facial nerve grafts are
sometimes performed at the time
of operation in patients whose
facial nerve cannot be saved.
Other techniques for facial
reanimation include the
hypoglossal to facial nerve
graft, static facial slings and
gold weight eyelid implants.
Please look at the
facial
paralysis page
for more information regarding
this problem.
-
Cerebrospinal fluid leak.
The brain is surrounded by
fluid, called cerebrospinal
fluid or CSF. Any time the dura
is opened, there is a potential
for leakage of CSF. Great care
is taken at the time of closure
to prevent this fluid from
leaking either out of the
incision site, the ear canal, or
the nose (by way of the
Eustachian tube). Regardless of
technique, CSF leak seems to
occur in about 10% of cases.
Treatment for CSF leak can
involve placing a drain in the
back (called a lumbar drain) to
remove spinal fluid and allow
the repair site to heal.
Sometimes additional surgical
procedures are necessary to stop
the fluid leak.
-
Meningitis. Meningitis
is inflammation or infection of
the coverings of the brain (the
meninges). Careful attention to
sterile technique and the use of
peri-operative antibiotics has
minimized the occurrence of
meningitis to 1-4%. If
meningitis does occur, a spinal
fluid tap will be performed to
find the organism that is
causing the infection and to
determine which antibiotics will
be most effective at curing the
infection.
-
Headache. Headache
following acoustic neuroma
surgery can be a sign of
meningitis. Sometimes, patients
who have had a retrosigmoid
approach will have headache that
persists for several months
following surgery. This
headache is usually relieved by
NSAIDs.
-
Other central
nervous system complications,
such as stroke, seizure, and
death, have been reported in
large surgical series; however,
their occurrence is rare (<1%).
Radiation has been used to treat
acoustic tumors for the past 20 or
so years. This procedure involves a
special form of radiation therapy
using a device commonly called the
Gamma Knife. More properly, it is a
stereotactic radiotherapy that can
deliver more than 200 beams of
radiation directed to the tumor
location. This concentrated dose of
focused radiation energy can destroy
tumor cells. This procedure is done
using local anesthesia and sedation
and is performed on an outpatient
basis. There is only one treatment
given.
The
advantage of this approach is the
avoidance of surgery, the period of
hospitalization, and the recovery
period necessary following
surgery. Initially, hearing
preservation and facial nerve
function can be higher than surgery;
however, long term results are
probably no different than that for
surgery.
The
disadvantage of this approach is
manifold. Although the radiation
does kill some tumor cells, it does
not kill all cells, and it does not
remove the tumor.
The
remaining cells might grow,
producing a recurrent tumor. In
those cases where a recurrent tumor
was surgically removed, the
procedure was technically more
difficult; and the post-operative
facial nerve function was poorer
than in surgical patients with
equivalent sized tumors without
prior radiation therapy. Facial
nerve weakness or paralysis has been
reported after Gamma knife therapy
alone. Sometimes this is due to
swelling in the tumor following
radiation. Hearing loss does occur
in patients who have Gamma Knife
therapy. Sometimes this hearing
loss occurs suddenly after treatment
or in several months after
treatment.
In
general, we have recommended Gamma
Knife therapy to patients who could
not otherwise have surgery and who
did not have a large tumor causing
central nervous system problems.
These
tumors are benign, meaning that they
do not spread throughout the body,
and slow growing. These patients
undergo serial MRI scans every 6 -
12 months, depending on the tumor's
rate of growth. Observation of the
tumor might be used in patients that
have very small tumors and who are
otherwise not good candidates for
the treatments listed above (e.g.
patients > 75 years of age with
complicating medical problems).
Surgery is usually required as
tumors grow out of the internal
auditory canal and into the
cerebellopontine angle and
brainstem.
However, in patients that are in
good health, have good hearing, and
have small tumors (< 1 cm), surgery
does offer the possibility of
complete removal with preservation
of hearing and facial nerve
function.
Concluding remarks
Acoustic neuromas are rare tumors
that grow on the vestibulocochlear
nerve. The symptoms of these tumors
include hearing loss, tinnitus,
imbalance, facial nerve weakness,
headache, etc. Surgical treatments
are very successful at removing
tumors, and preserving facial nerve
function. Hearing preservation can
be attempted in appropriately
selected patients. Radiation
therapy is available to patients,
especially those who could not
otherwise undergo surgery. Some
tumors are followed on serial MRI
examinations, especially in elderly
patients with small tumors.